Rosalind Advisors, Inc.
- SEC CIK
- 0001622627
- Latest filing
- Aug 14, 2026
FENC holding history
Fennec Pharmaceuticals Inc. in every 13F filed by Rosalind Advisors, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
FENC overviewAll 13F holders of FENCFull Q2 2026 holdings
- Shares (Q2 2026)
- 3,188,001
- Value
- $34.3M
- % of portfolio
- 12.9%
- Quarters held
- 7
- Since Q4 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 3,188,001 | $34.3M | 12.9% | +279,800+9.6% | Added | Holders |
| Q1 2026 | 2,908,201 | $17.9M | 7.3% | +294,693+11.3% | Added | Holders |
| Q4 2025 | 2,613,508 | $20.1M | 7.7% | +536,668+25.8% | Added | Holders |
| Q3 2025 | 2,076,840 | $19.4M | 7.1% | +31,196+1.5% | Added | Holders |
| Q2 2025 | 2,045,644 | $17.0M | 8.2% | +262,800+14.7% | Added | Holders |
| Q1 2025 | 1,782,844 | $10.9M | 5.3% | +522,968+41.5% | Added | Holders |
| Q4 2024 | 1,259,876 | $7.96M | 4.3% | +1,259,876 | New | Holders |